Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

EPS 0.2

$Exelixis(EXEL.US)$ that will beat expectation -0.03 to 0.23, but limited growth.
fda decision day Nov 4. Control you holding size. Could see a gap down (purely buyable), I’ll only buy as early as Friday.


update. Pro: good company, good sales growth and promising pipeline.
Con: Rude and boring conference cal… Our EPS is not big because they issued a lot of stock and option compensation.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
6
+0
3
Translate
Report
14K Views
Comment
Sign in to post a comment
CFA, FRM, P-Quant。然而自己投资并不量化…
185Followers
15Following
1594Visitors
Follow